{"id":78660,"date":"2023-09-26T16:43:21","date_gmt":"2023-09-26T11:13:21","guid":{"rendered":"http:\/\/finservwealth.com\/valiant-lab-ipo-10-things-to-know-before-subscribing-to-rs-152-cr-issue\/"},"modified":"2023-09-26T16:43:21","modified_gmt":"2023-09-26T11:13:21","slug":"valiant-lab-ipo-10-things-to-know-before-subscribing-to-rs-152-cr-issue","status":"publish","type":"post","link":"https:\/\/finservwealth.com\/hi\/valiant-lab-ipo-10-things-to-know-before-subscribing-to-rs-152-cr-issue\/","title":{"rendered":"Valiant Lab IPO: 10 things to know before subscribing to Rs 152 cr issue"},"content":{"rendered":"<p> Valiant Laboratories IPO | It plans to raise Rs 152.4 crore via the initial public offering, which consists of fresh issue of 1.09 crore shares. The company\u00e2\u20ac\u2122s anchor book opened for subscription on September 26<\/p><div id=\"finse-1974195403\" class=\"finse-content finse-entity-placement\"><script async src=\"\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-9118214110898834\" crossorigin=\"anonymous\"><\/script><ins class=\"adsbygoogle\" style=\"display:block;\" data-ad-client=\"ca-pub-9118214110898834\" \ndata-ad-slot=\"\" \ndata-ad-format=\"auto\"><\/ins>\n<script> \n(adsbygoogle = window.adsbygoogle || []).push({}); \n<\/script>\n<\/div>\n<p><a href=\"https:\/\/www.moneycontrol.com\/news\/ipo-news\/valiant-lab-ipo-10-things-to-know-before-subscribing-to-rs-152-cr-issue_17251121.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a><\/p>\n<p>\u200b\u00a0Valiant Laboratories IPO | It plans to raise Rs 152.4 crore via the initial public offering, which consists of fresh issue of 1.09 crore shares. The company\u00e2\u20ac\u2122s anchor book opened for subscription on September 26 Valiant Laboratories IPO | It plans to raise Rs 152.4 crore via the initial public offering, which consists of fresh issue of 1.09 crore shares. The company\u00e2\u20ac\u2122s anchor book opened for subscription on September 26\u00a0\u00a0Moneycontrol Latest News\u00a0<a href=\"https:\/\/www.moneycontrol.com\/news\/ipo-news\/valiant-lab-ipo-10-things-to-know-before-subscribing-to-rs-152-cr-issue_17251121.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a>\u00a0\u00a0<\/p>","protected":false},"excerpt":{"rendered":"<p><!-- wp:html --><\/p>\n<p> Valiant Laboratories IPO | It plans to raise Rs 152.4 crore via the initial public offering, which consists of fresh issue of 1.09 crore shares. The company\u00e2\u20ac\u2122s anchor book opened for subscription on September 26<\/p>\n<p><a href=\"https:\/\/www.moneycontrol.com\/news\/ipo-news\/valiant-lab-ipo-10-things-to-know-before-subscribing-to-rs-152-cr-issue_17251121.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a><\/p>\n<p>\u200b\u00a0Valiant Laboratories IPO | It plans to raise Rs 152.4 crore via the initial public offering, which consists of fresh issue of 1.09 crore shares. The company\u00e2\u20ac\u2122s anchor book opened for subscription on September 26 Valiant Laboratories IPO | It plans to raise Rs 152.4 crore via the initial public offering, which consists of fresh issue of 1.09 crore shares. The company\u00e2\u20ac\u2122s anchor book opened for subscription on September 26\u00a0\u00a0Moneycontrol Latest News\u00a0<a href=\"https:\/\/www.moneycontrol.com\/news\/ipo-news\/valiant-lab-ipo-10-things-to-know-before-subscribing-to-rs-152-cr-issue_17251121.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a>\u00a0\u00a0<\/p>\n<p><!-- \/wp:html --> Valiant Laboratories IPO | It plans to raise Rs 152.4 crore via the initial public offering, which consists of fresh issue of 1.09 crore shares. The company\u00e2\u20ac\u2122s anchor book opened for subscription on September 26<\/p>","protected":false},"author":0,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"content-type":"","_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"neve_meta_sidebar":"","neve_meta_container":"","neve_meta_enable_content_width":"","neve_meta_content_width":0,"neve_meta_title_alignment":"","neve_meta_author_avatar":"","neve_post_elements_order":"","neve_meta_disable_header":"","neve_meta_disable_footer":"","neve_meta_disable_title":"","_themeisle_gutenberg_block_has_review":false,"footnotes":""},"categories":[70],"tags":[],"class_list":["post-78660","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-latest-news"],"jetpack_featured_media_url":"https:\/\/www.moneycontrol.com\/news_image_files\/2019\/200x200\/m\/medicine-_200.jpg","_links":{"self":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts\/78660","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/comments?post=78660"}],"version-history":[{"count":0,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts\/78660\/revisions"}],"wp:attachment":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/media?parent=78660"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/categories?post=78660"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/tags?post=78660"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}